Gerresheimer (ETR:GXI) Given a €61.00 Price Target at JPMorgan Chase & Co.

JPMorgan Chase & Co. set a €61.00 ($70.93) target price on Gerresheimer (ETR:GXI) in a research report report published on Tuesday, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

A number of other brokerages have also weighed in on GXI. Deutsche Bank set a €83.00 ($96.51) price target on shares of Gerresheimer and gave the stock a buy rating in a research note on Monday, October 14th. HSBC set a €85.00 ($98.84) price objective on shares of Gerresheimer and gave the company a buy rating in a research note on Monday, October 14th. Berenberg Bank set a €81.00 ($94.19) price objective on shares of Gerresheimer and gave the company a buy rating in a research note on Thursday, October 10th. Independent Research set a €69.00 ($80.23) target price on Gerresheimer and gave the stock a neutral rating in a report on Tuesday, October 15th. Finally, Hauck & Aufhaeuser set a €50.00 ($58.14) target price on Gerresheimer and gave the stock a sell rating in a research report on Thursday, October 10th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and four have given a buy rating to the stock. Gerresheimer presently has a consensus rating of Hold and an average price target of €71.11 ($82.69).

GXI stock traded down €0.35 ($0.41) on Tuesday, reaching €66.65 ($77.50). The company’s stock had a trading volume of 281,416 shares, compared to its average volume of 140,925. Gerresheimer has a 52 week low of €51.10 ($59.42) and a 52 week high of €74.80 ($86.98). The company has a market capitalization of $2.09 billion and a P/E ratio of 10.11. The firm has a fifty day moving average of €68.99 and a two-hundred day moving average of €67.92. The company has a debt-to-equity ratio of 65.99, a current ratio of 0.81 and a quick ratio of 0.54.

About Gerresheimer

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

See Also: What is the Bid-Ask Spread?

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.